Technical Analysis for KMPH - KemPharm, Inc.

Grade Last Price % Change Price Change
grade F 1.98 -1.98% -0.04
KMPH closed down 1.98 percent on Friday, March 22, 2019, on 2.36 times normal volume.
1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical KMPH trend table...

Date Alert Name Type % Chg
Mar 22 Down 3 Days in a Row Weakness 0.00%
Mar 21 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.98%
Mar 21 Spinning Top Other -1.98%
Mar 21 NR7 Range Contraction -1.98%
Mar 21 NR7-2 Range Contraction -1.98%
Mar 21 Inside Day Range Contraction -1.98%
Mar 20 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.88%
Mar 20 NR7 Range Contraction -3.88%
Mar 19 Pocket Pivot Bullish Swing Setup -5.26%
Mar 19 Inside Day Range Contraction -5.26%

Older signals for KMPH ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:
Profile
KemPharm is a specialty pharmaceutical company focused on the discovery and development of NME prodrugs to treat serious medical conditions through its Ligand Activated Therapy (LAT) platform technology. KemPharm utilizes its LAT platform technology to generate improved prodrug versions of FDA-approved drugs in the high needs areas of pain, ADHD and other CNS disorders.
Health Pharmaceutical Pharmaceutical Industry Pain Medication FDA Pharmacokinetics Platform Technology Attention Deficit Hyperactivity Disorder Adhd Amphetamine Methylphenidate
Is KMPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Mar 18 KemPharm: Will Optimism Win?
Mar 13 KemPharm down 6% premarket on Apadaz coverage update
Mar 13 KemPharm Provides Update on APADAZ® Formulary Adoption
Mar 7 Loss-Making KemPharm, Inc. (NASDAQ:KMPH) Expected To Breakeven
Mar 5 KemPharm to Present at Upcoming Investor Conferences
Mar 3 Edited Transcript of KMPH earnings conference call or presentation 28-Feb-19 9:30pm GMT
Mar 1 KemPharm (KMPH) CEO Travis Mickle on Q4 2018 Results - Earnings Call Transcript
Feb 28 Penny Stocks to Buy Using Technical Analysis for March 2019
Feb 28 KemPharm beats by $0.32
Feb 28 KemPharm Reports Q4 and FY 2018 Results
See more KMPH news...
Indicators
Indicator Value
52 Week High 8.0
52 Week Low 1.715
Average Volume 133,851
200-Day Moving Average 3.5697
50-Day Moving Average 2.3694
20-Day Moving Average 2.1055
10-Day Moving Average 2.052
Average True Range 0.1798
ADX 12.63
+DI 16.9687
-DI 19.365
Chandelier Exit (Long, 3 ATRs ) 2.0306
Chandelier Exit (Short, 3 ATRs ) 2.4094
Upper Bollinger Band 2.3683
Lower Bollinger Band 1.8427
Percent B (%b) 0.26
BandWidth 24.963192
MACD Line -0.0876
MACD Signal Line -0.0938
MACD Histogram 0.0063
Fundamentals Value
Market Cap 29.02 Million
Num Shares 14.7 Million
EPS -3.10
Price-to-Earnings (P/E) Ratio -0.64
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.16
Resistance 3 (R3) 2.16 2.10 2.13
Resistance 2 (R2) 2.10 2.05 2.10 2.12
Resistance 1 (R1) 2.04 2.03 2.01 2.04 2.11
Pivot Point 1.98 1.98 1.97 1.98 1.98
Support 1 (S1) 1.92 1.93 1.89 1.92 1.85
Support 2 (S2) 1.86 1.91 1.86 1.84
Support 3 (S3) 1.80 1.86 1.83
Support 4 (S4) 1.80